22 Logie Mill
Beaverbank Business Park
Edinburgh, EH7 4HG
United Kingdom
Public / Non-Profit Organizations / Medical Facilities
Other, Research facility
Myeloma UK is the only charity in the United Kingdom dedicated exclusively to myeloma, an incurable but treatable blood cancer that develops in the bone marrow's plasma cells. The organisation operates entirely on voluntary donations and fundraising to support patients, advance clinical research, and accelerate access to newer treatments.
Holywell Way
Luinc Holywell Building, Leicestershire
Loughborough, LE11 3UZ
United Kingdom
Biotechnology - R&D Services
Analytical services, CRO (Contract Research Organization), Screening
Myomaker Bio Ltd is the biotechnology company which focuses on drug discovery and development stage related to muscle biology. The company provides contract resesrch services on screening, and partnership development of advanced organ models. Muscle morphology, muscle function analysis are performed using the human-relevant 3D muscle models and precision assays.
80 Wood Lane
Translation & Innovation Hub, Imperial College White City Campus
London, W12 0BZ
United Kingdom
Supplier & Engineering
Instrumentation, Laboratory equipment
Mytos has developed an automated platform that handles the manual and complex tasks associated with mammalian cell culture. The company's iDEM™ platform, is an automated manufacturing system designed for the production of mammalian cells. This technology is utilized by biotechnology and pharmaceutical companies to standardize the growth and differentiation of human cells for use in clinical trials and therapeutic applications.
Alderley Park
Alderley Edge
Cheshire, SK10 7TG
United Kingdom
Biotechnology - Therapeutics and Diagnostics
Antibodies, Drug delivery, Peptides, Proteins, Natural Compounds
Diseases of the eye / ophthalmology
NanOptima’s propriety NAAmatrix™ is engineered to address one of ophthalmology’s biggest unmet needs: injection durability and adherence crisis. Anti-VEGF drugs work: clinical trials deliver 8–10 ETDRS letter gains. The real world delivers 1.5–3.5. The gap is not efficacy, it is durability. Approximately 50% of patients discontinue treatment by year two, driving irreversible, preventable vision loss at scale. Patients and healthcare systems cannot sustain 1-3 monthly injections.
NAAmatrix™ is a bioresorbable natural amino-acid matrix that extends proven anti-VEGF biologics, peptides, and small molecules to >6 months from a single standard 30G intravitreal injection. No device. No surgery. No curing. No drug modification. No workflow change (frictionless clinical practice). Clean 28-day in vivo tolerability confirmed. Six-month in vitro sustained release confirmed. Aflibercept showing > 6 months and TKI data now showing >8 months. GB priority patent filed.
Sir William Lyons Road
The Venture Centre, University of Warwick Science Park
Coventry, CV47EZ
United Kingdom
Biotechnology - Therapeutics and Diagnostics
Drug delivery, Peptides, Proteins
NanoSyrinx is a discovery stage synthetic biology company developing a novel “nanosyringe” system by delivering therapeutic proteins and peptides direct to the cytosol in a targeted manner. NanoSyrinx’s proprietary platform utilises a core suite of genes, encoding the syringe ‘chassis’, the biological payloads and cell targeting domains which, when expressed, self-assemble in a single step to produce fully formed Nanosyringes.
Draymans Way
The Biosphere
Newcastle Upon Tyne, NE4 5BX
United Kingdom
Biotechnology - R&D Services
Analytical services, Diagnostic instrumentation, Diagnostic services
Infectious and parasitic diseases / infectiology / parasitology, Neoplasms / cancer / oncology, Digestive system / gastroenterology, Genitourinary system / Urology, Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified, Injury, poisoning and certain other consequences of external causes / toxicology
Nanovery Ltd. is developing a point-of care diagnostic solution, offering an innovative method of detecting and monitoring the most devastating diseases. The solution makes use of pioneering DNA nanotechnology and DNA computing techniques to create nanosensors that recognise trace amount of disease biomarkers in patient samples (blood, urine, etc). When the DNA/RNA biomarker is detected, the sensor releases a fluorescent signal, thus giving a rapid response to a clinician, indicating the need for further investigation.
Hertfordshire,
United Kingdom
Public / Non-Profit Organizations / Medical Facilities
Governmental organization, Research facility
The National Institute for Health and Care Research (NIHR) serves as the primary government agency for health and social care research in the United Kingdom, funded through the Department of Health and Social Care. Its objective is to maintain a comprehensive research system that integrates the National Health Service (NHS) with specialized infrastructure, world-class facilities, and professional training for researchers. By focusing on the specific needs of patients, service users, and the public, the organization aims to improve national health outcomes and contribute to the UK’s economic wealth through partnerships with the life sciences industry.
Begbroke Science & Innovation, Oxfordshire
Oxford, OX5 1PF
United Kingdom
Public / Non-Profit Organizations / Medical Facilities
Foundation
Nekton Foundation is a charitable organization focused on advancing scientific exploration and conservation of the global ocean. The foundation organizes large-scale ocean expeditions that map unexplored marine ecosystems, discover new species, and collect scientific data for conservation and policy development. Nekton Foundation's work emphasizes open science, with research conducted jointly with host nations and international scientific institutions. Nekton collaborates with governments, universities, research institutes, philanthropic organizations, and industry partners to deliver multidisciplinary ocean exploration programs. The organization also promotes public awareness of ocean science through documentaries, educational initiatives, and cultural engagement. Scientific findings generated by Nekton are intended to support marine protected areas, sustainable ocean management, and global biodiversity commitments.
Midland Rd
Science Creates - Old Market
Bristol, BS2 0NS
United Kingdom
Biotechnology - Other
Environmental
neo-fossil LTD is aiming to develop engineered cells to store atmospheric CO2 for centuries.
127 Olympic Avenue
Unit 1&2 West
Milton Park, OX14 4SA
United Kingdom
Biotechnology - Therapeutics and Diagnostics
Drug delivery, Nucleic acid drugs, Vaccines
Infectious and parasitic diseases / infectiology / parasitology, Neoplasms / cancer / oncology, Respiratory / pulmonology, Digestive system / gastroenterology
NeoVac is developing a LNP platform to deliver improved mRNA vaccines and treatments for various diseases.
The company's proprietary next generation lipid nanoparticles enable better RNA vaccines. The aim is to make RNA vaccines more transportable, with broader capabilities and less side effects.
38 Hyde Park Gate
London, SW7 5DP
United Kingdom
Professional Services and Consulting
Other
NFIA helps and advises foreign companies in all phases of establishing, rolling out and/or expanding their international activities in the Netherlands. NFIA’s free and confidential services include organizing fact-finding missions; arranging meetings with relevant partners; and providing personalized guidance and counsel on tax, government, labor and permit procedures, location options and business solutions.
Chilvester Hill, Chilvester lodge
Calne, SN11 0LP
United Kingdom
Pharma (fully integrated)
Other
Infectious and parasitic diseases / infectiology / parasitology
Neurone Ltd is a UK-based pharmaceutical development SME specializing in complex botanical medicines and cannabinoids. The company uses complex botanical extracts, obtained from botanical raw material grown in licensed growing facility, to create novel extract based pharmaceutical products. Neurone develop IP protected, complex botanical medicines, executing the clinical trials required to secure FDA and other international regulatory approvals in order to enable prescribing and reimbursement needed to achieve broad patient access.
Wilbury Way
75-77 Knowl Piece
Hitchin, SG4 0TY
United Kingdom
Supplier & Engineering
Distributors, Laboratory consumables and reagents
New England Biolabs, Inc. is active in the production and supply of reagents for the life science industry. The UK subsidiary office of New England Biolabs provides sales and technical support to their customers in the UK.
66 Regent's Park Road
London, NW1 7SX
United Kingdom
Biotechnology - Therapeutics and Diagnostics
Anti-infectives, Peptides, Immunotherapy
Infectious and parasitic diseases / infectiology / parasitology, Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology
Newal R&D Ltd is a immune-pharmaceutical company developing ezrin-peptide for human health, based on patent protected and innovative platform technology.
Newal R&D is currently developing generation-3 and generation-4 synthetic ezrin peptide products, initially as a one-stop therapy for the treatment of all sexually transmitted infections. NewalR&D is also developing ezrin peptides for the treatment of age-related chronic inflammatory diseases, for the treatment of long COVID and COVID-vaccine injury.
1 Thornbury Gardens
Borehamwood, WD6 1RB
United Kingdom
Biotechnology - R&D Services
Other
Endocrine, nutritional and metabolic diseases / endocrinology, Diseases of the nervous system / neurology
Newcleic Ltd is a UK-based biotechnology company focused on developing next-generation DNA manufacturing technologies. The company specializes in advanced long DNA production platforms combined with artificial intelligence and machine learning approaches to support applications in plant breeding, biotechnology, therapeutics, and agricultural innovation. Newcleic aims to make DNA design and production faster, more accurate, and more accessible, enabling the development of improved crop varieties and other biological solutions.
1 Robert Robinson Avenue
Magdalen Centre
Oxford, OX4 4GA
United Kingdom
Medical Technology
Biomaterials, Regenerative Medicine, Single use devices
Diseases of the nervous system / neurology, Musculoskeletal system and connective tissue / Orthopedics
Newrotex is developing nerve stents produced from medical grade silk to treat peripheral nerve injury (PNI). The company's 'off-the-shelf' device allows immediate treatment for patients who have suffered injury through trauma or cancer surgery, without any of the associated risks of the current gold-standard treatment of autografts.
77 Heyford Park
Cherwell Innovation Centre, Upper Heyford
Bicester, OX25 5HD
United Kingdom
Biotechnology - R&D Services
Bioelectronics, Drug delivery
Nikalyte Ltd is a leading supplier of nanoparticle coating equipment and services for R&D and commercial use in a wide variety of application areas including cell binding, cell separation, drug delivery, catalysis, metamaterials, nano-photonics, electrochemistry and battery technology.
1 The Crescent
Surbiton, Surrey
London, KT6 4BN
United Kingdom
Supplier & Engineering
Distributors, Electronics, Laboratory equipment
Nikon UK manufactures electronic products. The company offers products such as digital cameras, film cameras, lenses, speed lights, film scanners, semiconductors, LCD panels, and other products. Nikon operates worldwide. Nikon Imaging Centers and Nikon Centers of Excellence are cutting-edge facilities formed through partnerships with leading research institutes.
Fruebjergvej 3
Symbion Science Park
Copenhagen, 2100
Denmark
Professional Services and Consulting
Business development, Deal arranger, Information provider, Technology transfer
Nordic Mentor Network for Entrepreneurship is a Nordic mentoring program for promising life science projects and start-ups. NOME matches Nordic projects and startups with volunteer professionals to help them reach their goals and technology milestones.
66 Goulburn Street
level 19
Sydney, 2000
Australia
Biotechnology - R&D Services
CRO (Contract Research Organization)
Novotech is a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug development at every phase. Novotech provides clients an accelerated path to bring life-changing therapies to market by providing access to key clinical trial destinations and diverse patient populations.
Through its client-centric service model, Novotech seamlessly integrates people, processes, and technologies to deliver customized solutions that accelerate the path to market for life-changing therapies. Together with clients, Novotech transforms scientific advancements into therapies that improve global health outcomes, embodying a mission of driving innovation and delivering impactful results.